Clostridial collagenase for the management of diabetic foot ulcers: Results of four randomized controlled trials
Wounds Sep 05, 2017
Lantis JC, et al. – An assessment and comparison were carried out of the clinical effectiveness of clostridial collagenase ointment (CCO) with standard care (SC) in patients with diabetic foot ulcers (DFUs). The intent was to define the best clinical criteria for the utility of CCO in the study cohort. A correlation was brought to light between active CCO therapy with a nonstatistically greater reduction in wound size than any of the passive or mechanical SC modalities at end of the therapy. This was found to be prominent when used in conjunction with sharp debridement and for slow healing ulcers, larger sized wounds or plantar surface wounds.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries